Literature DB >> 12885446

Radiotherapy of small intracranial tumours with different advanced techniques using photon and proton beams: a treatment planning study.

Alessandra Bolsi1, Antonella Fogliata, Luca Cozzi.   

Abstract

BACKGROUND AND
PURPOSE: The potential benefits and limitations of five different radiation techniques, 3D conformal radiotherapy (3DCRT), stereotactic arc therapy (SRS/T), intensity modulated radiotherapy with photons (IMRT), and radiotherapy with protons (spot scanning (SSp) or passive scattering (PSp)), have been assessed using comparative treatment planning methods in a cohort of patients presenting with 'benign' brain tumours.
MATERIAL AND METHODS: Plans for five acoustic neurinomas, five meningiomas, and two pituitary adenomas were computed for all modalities using computed tomography (CT) scans to delineate planning target volume and organs at risk (OARs) and to predict dose distributions. Dose-volume histograms were used for physical and simple biological evaluation.
RESULTS: Proton techniques were shown to be superior to all photon approaches for the irradiation of small brain lesions in terms of target dose uniformity and conformity and in terms of sparing OARs. No major differences were observed between the results of the photon techniques, which were generally good for target coverage. Minimum target doses ranged from 81% with SRS/T to 93% with IMRT. The volume receiving more than 95% of the dose ranged from 95% (SRS/T) to 99% (PSp). No clear patterns of coverage dependence upon target shape were observed. Maximum brain stem irradiation ranged from 60% with IMRT to 26% with protons and the conformity index from 4.4 with IMRT to 2.5 with protons. Considering the rather long life expectancy of the patients suffering from meningiomas, neurinomas, and pituitary adenomas, the most important aspect to be considered, other than target coverage, is toxicity and in the long term, the possibility of secondary tumour induction. Considering these aspects, proton irradiation should be the irradiation technique of choice, when available. If not, IMRT, or even 3DCRT, techniques can provide an acceptable compromise, even without recurring to unconventional treatments like SRS/T, which require complex installations and high machine occupancy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12885446     DOI: 10.1016/s0167-8140(03)00117-8

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  12 in total

1.  Technical Note: Optimization of spot and trimmer position during dynamically collimated proton therapy.

Authors:  Blake R Smith; Daniel E Hyer; Ryan T Flynn; Wesley S Culberson
Journal:  Med Phys       Date:  2019-03-05       Impact factor: 4.071

2.  Trimmer sequencing time minimization during dynamically collimated proton therapy using a colony of cooperating agents.

Authors:  Blake R Smith; Daniel E Hyer; Ryan T Flynn; Patrick M Hill; Wesley S Culberson
Journal:  Phys Med Biol       Date:  2019-10-21       Impact factor: 3.609

Review 3.  Particle therapy in the future of precision therapy.

Authors:  Lukas Schaub; Semi Ben Harrabi; Juergen Debus
Journal:  Br J Radiol       Date:  2020-08-14       Impact factor: 3.629

Review 4.  Meningioma: current treatment options and future directions.

Authors:  Kevin P McMullen; Volker W Stieber
Journal:  Curr Treat Options Oncol       Date:  2004-12

5.  Comparison of intensity modulated radiotherapy (IMRT) with intensity modulated particle therapy (IMPT) using fixed beams or an ion gantry for the treatment of patients with skull base meningiomas.

Authors:  Katsura Kosaki; Swantje Ecker; Daniel Habermehl; Stefan Rieken; Oliver Jäkel; Klaus Herfarth; Jürgen Debus; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2012-03-22       Impact factor: 3.481

6.  A phase II multi-institutional study assessing simultaneous in-field boost helical tomotherapy for 1-3 brain metastases.

Authors:  George Rodrigues; Slav Yartsev; Keng Yeow Tay; Gregory R Pond; Frank Lagerwaard; Glenn Bauman
Journal:  Radiat Oncol       Date:  2012-03-21       Impact factor: 3.481

7.  Predictive Risk of Radiation Induced Cerebral Necrosis in Pediatric Brain Cancer Patients after VMAT Versus Proton Therapy.

Authors:  Derek Freund; Rui Zhang; Mary Sanders; Wayne Newhauser
Journal:  Cancers (Basel)       Date:  2015-04-10       Impact factor: 6.639

8.  A treatment planning study of proton arc therapy for para-aortic lymph node tumors: dosimetric evaluation of conventional proton therapy, proton arc therapy, and intensity modulated radiotherapy.

Authors:  Jeong-Eun Rah; Gwe-Ya Kim; Do Hoon Oh; Tae Hyun Kim; Jong Won Kim; Dae Yong Kim; Sung Yong Park; Dongho Shin
Journal:  Radiat Oncol       Date:  2016-10-21       Impact factor: 3.481

9.  Monitor unit optimization in RapidArc plans for prostate cancer.

Authors:  Stefania Clemente; Mariella Cozzolino; Costanza Chiumento; Alba Fiorentino; Rocchina Caivano; Vincenzo Fusco
Journal:  J Appl Clin Med Phys       Date:  2013-05-06       Impact factor: 2.102

10.  MRI-Related Geometric Distortions in Stereotactic Radiotherapy Treatment Planning: Evaluation and Dosimetric Impact.

Authors:  Eleftherios P Pappas; Mukhtar Alshanqity; Argyris Moutsatsos; Hani Lababidi; Khalid Alsafi; Konstantinos Georgiou; Pantelis Karaiskos; Evangelos Georgiou
Journal:  Technol Cancer Res Treat       Date:  2017-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.